Fosamax is a drug developed by Merck Laboratories to treat osteoporosis and other bone-related diseases. It has proven to increase bone density in post-menopausal women and to reduce fractures; it is also used to treat osteoporosis in men. Merck introduced Fosomax to not only halt the progression of bone deterioration, but to contribute to an increase in bone mass for individuals who are at a point in their lives when bone deterioration is a common threat.
“Fosamax can cause the thigh bone to snap like a twig…”
Doctors are now reporting seeing an increase in femurs fractures in patients who have been on the drug.
If you or someone you know has taken Fosamax ® or its generic form Alendronate ® and suffered a femur fracture, please fill out the ‘Free Case Evaluation’ form and a lawyer with experience in Fosamax litigation will contact you.